Search

Your search keyword '"Golub, Robert M"' showing total 535 results
Start Over Author "Golub, Robert M" Language english
535 results on '"Golub, Robert M"'

1. Author Correction: Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines

Author

Martindale, Alexander P. L., Llewellyn, Carrie D., de Visser, Richard O., Ng, Benjamin, Ngai, Victoria, Kale, Aditya U., di Ruffano, Lavinia Ferrante, Golub, Robert M., Collins, Gary S., Moher, David, McCradden, Melissa D., Oakden-Rayner, Lauren, Rivera, Samantha Cruz, Calvert, Melanie, Kelly, Christopher J., Lee, Cecilia S., Yau, Christopher, Chan, An-Wen, Keane, Pearse A., Beam, Andrew L., Denniston, Alastair K., and Liu, Xiaoxuan

Published
2024
Full Text
View/download PDF

2. Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines

Author

Martindale, Alexander P. L., Llewellyn, Carrie D., de Visser, Richard O., Ng, Benjamin, Ngai, Victoria, Kale, Aditya U., di Ruffano, Lavinia Ferrante, Golub, Robert M., Collins, Gary S., Moher, David, McCradden, Melissa D., Oakden-Rayner, Lauren, Rivera, Samantha Cruz, Calvert, Melanie, Kelly, Christopher J., Lee, Cecilia S., Yau, Christopher, Chan, An-Wen, Keane, Pearse A., Beam, Andrew L., Denniston, Alastair K., and Liu, Xiaoxuan

Published
2024
Full Text
View/download PDF

3. Recommendations to address respondent burden associated with patient-reported outcome assessment

Author

Aiyegbusi, Olalekan Lee, Cruz Rivera, Samantha, Roydhouse, Jessica, Kamudoni, Paul, Alder, Yvonne, Anderson, Nicola, Baldwin, Robert Mitchell, Bhatnagar, Vishal, Black, Jennifer, Bottomley, Andrew, Brundage, Michael, Cella, David, Collis, Philip, Davies, Elin-Haf, Denniston, Alastair K., Efficace, Fabio, Gardner, Adrian, Gnanasakthy, Ari, Golub, Robert M., Hughes, Sarah E., Jeyes, Flic, Kern, Scottie, King-Kallimanis, Bellinda L., Martin, Antony, McMullan, Christel, Mercieca-Bebber, Rebecca, Monteiro, Joao, Peipert, John Devin, Quijano-Campos, Juan Carlos, Quinten, Chantal, Rantell, Khadija Rerhou, Regnault, Antoine, Sasseville, Maxime, Schougaard, Liv Marit Valen, Sherafat-Kazemzadeh, Roya, Snyder, Claire, Stover, Angela M., Verdi, Rav, Wilson, Roger, and Calvert, Melanie J.

Published
2024
Full Text
View/download PDF

4. Developing specific reporting guidelines for diagnostic accuracy studies assessing AI interventions: The STARD-AI Steering Group

Author

Sounderajah, Viknesh, Ashrafian, Hutan, Aggarwal, Ravi, De Fauw, Jeffrey, Denniston, Alastair K., Greaves, Felix, Karthikesalingam, Alan, King, Dominic, Liu, Xiaoxuan, Markar, Sheraz R., McInnes, Matthew D. F., Panch, Trishan, Pearson-Stuttard, Jonathan, Ting, Daniel S. W., Golub, Robert M., Moher, David, Bossuyt, Patrick M., and Darzi, Ara

Published
2020
Full Text
View/download PDF

5. Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.

Author

Kahan, Brennan C., Hall, Sophie S., Beller, Elaine M., Birchenall, Megan, Chan, An-Wen, Elbourne, Diana, Little, Paul, Fletcher, John, Golub, Robert M., Goulao, Beatriz, Hopewell, Sally, Islam, Nazrul, Zwarenstein, Merrick, Juszczak, Edmund, and Montgomery, Alan A.

Subjects
FACTORIALS, CRIME & the press, FACTORIAL experiment designs
Abstract

Importance: Transparent reporting of randomized trials is essential to facilitate critical appraisal and interpretation of results. Factorial trials, in which 2 or more interventions are assessed in the same set of participants, have unique methodological considerations. However, reporting of factorial trials is suboptimal. Objective: To develop a consensus-based extension to the Consolidated Standards of Reporting Trials (CONSORT) 2010 Statement for factorial trials. Design: Using the Enhancing the Quality and Transparency of Health Research (EQUATOR) methodological framework, the CONSORT extension for factorial trials was developed by (1) generating a list of reporting recommendations for factorial trials using a scoping review of methodological articles identified using a MEDLINE search (from inception to May 2019) and supplemented with relevant articles from the personal collections of the authors; (2) a 3-round Delphi survey between January and June 2022 to identify additional items and assess the importance of each item, completed by 104 panelists from 14 countries; and (3) a hybrid consensus meeting attended by 15 panelists to finalize the selection and wording of items for the checklist. Findings: This CONSORT extension for factorial trials modifies 16 of the 37 items in the CONSORT 2010 checklist and adds 1 new item. The rationale for the importance of each item is provided. Key recommendations are (1) the reason for using a factorial design should be reported, including whether an interaction is hypothesized, (2) the treatment groups that form the main comparisons should be clearly identified, and (3) for each main comparison, the estimated interaction effect and its precision should be reported. Conclusions and Relevance: This extension of the CONSORT 2010 Statement provides guidance on the reporting of factorial randomized trials and should facilitate greater understanding of and transparency in their reporting. This article provides an extension of the Consolidated Standards of Reporting Trials 2010 checklist for the reporting of factorial trials. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

7. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension

Author

Calvert, Melanie, Kyte, Derek, Mercieca-Bebber, Rebecca, Slade, Anita, Chan, An-Wen, King, Madeleine T., Hunn, Amanda, Bottomley, Andrew, Regnault, Antoine, Chan, An-Wen, Ells, Carolyn, O’Connor, Daniel, Revicki, Dennis, Patrick, Donald, Altman, Doug, Basch, Ethan, Velikova, Galina, Price, Gary, Draper, Heather, Blazeby, Jane, Scott, Jane, Coast, Joanna, Norquist, Josephine, Brown, Julia, Haywood, Kirstie, Johnson, Laura Lee, Campbell, Lisa, Frank, Lori, von Hildebrand, Maria, Brundage, Michael, Palmer, Michael, Kluetz, Paul, Stephens, Richard, Golub, Robert M., Mitchell, Sandra, and Groves, Trish

Published
2018
Full Text
View/download PDF

10. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): Explanation and elaboration

Author

Skrivankova, Veronika W, Richmond, Rebecca C, Woolf, Benjamin A R, Davies, Neil M, Swanson, Sonja A, VanderWeele, Tyler J, Timpson, Nicholas J, Higgins, Julian P T, Dimou, Niki, Langenberg, Claudia, Loder, Elizabeth W, Golub, Robert M, Egger, Matthias, Davey Smith, George, Richards, J Brent, Epidemiology, Langenberg, Claudia [0000-0002-5017-7344], and Apollo - University of Cambridge Repository

Subjects
Observational Studies as Topic, 360 Social problems & social services, Epidemiologic Research Design, Research Methods & Reporting, Humans, 610 Medicine & health, Guidelines as Topic, Mendelian Randomization Analysis
Abstract

Mendelian randomisation (MR) studies allow a better understanding of the causal effects of modifiable exposures on health outcomes, but the published evidence is often hampered by inadequate reporting. Reporting guidelines help authors effectively communicate all critical information about what was done and what was found. STROBE-MR (strengthening the reporting of observational studies in epidemiology using mendelian randomisation) assists authors in reporting their MR research clearly and transparently. Adopting STROBE-MR should help readers, reviewers, and journal editors evaluate the quality of published MR studies. This article explains the 20 items of the STROBE-MR checklist, along with their meaning and rationale, using terms defined in a glossary. Examples of transparent reporting are used for each item to illustrate best practices.

Published
2021
Full Text
View/download PDF

21. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances

Author

Orkin, Aaron M., Gill, Peter J., Ghersi, Davina, Campbell, Lisa, Sugarman, Jeremy, Emsley, Richard, Steg, Philippe Gabriel, Weijer, Charles, Simes, John, Rombey, Tanja, Williams, Hywel C., Wittes, Janet, Moher, David, Richards, Dawn P., Kasamon, Yvette, Getz, Kenneth, Hopewell, Sally, Dickersin, Kay, Wu, Taixiang, Ayala, Ana Patricia, Schulz, Kenneth F., Calleja, Sabine, Boutron, Isabelle, Ross, Joseph S., Golub, Robert M., Khan, Karim M., Mulrow, Cindy, Siegfried, Nandi, Heber, Joerg, Lee, Naomi, Kearney, Pamela Reed, Wanyenze, Rhoda K., Hróbjartsson, Asbjørn, Williams, Rebecca, Bhandari, Nita, Jüni, Peter, Chan, An-Wen, Kiermer, Veronique, Corrigan-Curay, Jacqueline, and Concato, John

Subjects
Coronavirus, COVID-19
Abstract

Importance: Extenuating circumstances can trigger unplanned changes to randomized trials and introduce methodological, ethical, feasibility, and analytical challenges that can potentially compromise the validity of findings. Numerous randomized trials have required changes in response to the COVID-19 pandemic, but guidance for reporting such modifications is incomplete. Objective: As a joint extension for the CONSORT and SPIRIT reporting guidelines, CONSERVE (CONSORT and SPIRIT Extension for RCTs Revised in Extenuating Circumstances) aims to improve reporting of trial protocols and completed trials that undergo important modifications in response to extenuating circumstances. Evidence: A panel of 37 international trial investigators, patient representatives, methodologists and statisticians, ethicists, funders, regulators, and journal editors convened to develop the guideline. The panel developed CONSERVE following an accelerated, iterative process between June 2020 and February 2021 involving (1) a rapid literature review of multiple databases (OVID Medline, OVID EMBASE, and EBSCO CINAHL) and gray literature sources from 2003 to March 2021; (2) consensus-based panelist meetings using a modified Delphi process and surveys; and (3) a global survey of trial stakeholders. Findings: The rapid review yielded 41 673 citations, of which 38 titles were relevant, including emerging guidance from regulatory and funding agencies for managing the effects of the COVID-19 pandemic on trials. However, no generalizable guidance for all circumstances in which trials and trial protocols might face unanticipated modifications were identified. The CONSERVE panel used these findings to develop a consensus reporting guidelines following 4 rounds of meetings and surveys. Responses were received from 198 professionals from 34 countries, of whom 90% (n = 178) indicated that they understood the concept definitions and 85.4% (n = 169) indicated that they understood and could use the implementation tool. Feedback from survey respondents was used to finalize the guideline and confirm that the guideline's core concepts were applicable and had utility for the trial community. CONSERVE incorporates an implementation tool and checklists tailored to trial reports and trial protocols for which extenuating circumstances have resulted in important modifications to the intended study procedures. The checklists include 4 sections capturing extenuating circumstances, important modifications, responsible parties, and interim data analyses. Conclusions and Relevance: CONSERVE offers an extension to CONSORT and SPIRIT that could improve the transparency, quality, and completeness of reporting important modifications to trials in extenuating circumstances such as COVID-19.

Published
2021

39. A call for transparent reporting to optimize the predictive value of preclinical research

Author

Landis, Story C., Amara, Susan G., Asadullah, Khusru, Austin, Chris P., Blumenstein, Robi, Bradley, Eileen W., Crystal, Ronald G., Darnell, Robert B., Ferrante, Robert J., Fillit, Howard, Finkelstein, Robert, Fisher, Marc, Gendelman, Howard E., Golub, Robert M., Goudreau, John L., Gross, Robert A., Gubitz, Amelie K., Hesterlee, Sharon E., Howells, David W., Huguenard, John, Kelner, Katrina, Koroshetz, Walter, Krainc, Dimitri, Lazic, Stanley E., Levine, Michael S., Macleod, Malcolm R., McCall, John M., Moxley, Richard T., III, Narasimhan, Kalyani, Noble, Linda J., Perrin, Steve, Porter, John D., Steward, Oswald, Unger, Ellis, Utz, Ursula, and Silberberg, Shai D.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results